4//SEC Filing
Jin David 4
Accession 0001104659-23-078098
CIK 0001644963other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:09 PM ET
Size
6.0 KB
Accession
0001104659-23-078098
Insider Transaction Report
Form 4
Jin David
Int. PEO, Int. PFO, and COO
Transactions
- Award
Employee stock option (right to buy)
2023-06-30+250,000→ 250,000 totalExercise: $1.14Exp: 2033-06-30→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]The option vests in accordance with the following schedule: (i) 25% of the shares subject to the option vest on August 1, 2023; (ii) 25% of the shares subject to the option vest on August 1, 2024; (iii) 25% of the shares subject to the option vest on August 1, 2025; and (iv) 25% of the shares subject to the option vest on August 1, 2026.
- [F2]Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Documents
Issuer
AVENUE THERAPEUTICS, INC.
CIK 0001644963
Entity typeother
Related Parties
1- filerCIK 0001930732
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:09 PM ET
- Size
- 6.0 KB